Search clinical trials for: Resiquimod

Total 24 results

Spirig Pharma Ltd.

Completed

Dose-finding, Safety, Efficacy Trial of Topical Resiquimod in Patients With Multiple Actinic Keratosis Lesions

Actinic Keratosis

Switzerland, Germany
Spirig Pharma Ltd.

Terminated

Efficacy and Safety Trial of Topical Resiquimod Gel (0.06%) in Patients With Nodular Basal Cell Carcinoma

Nodular Basal Cell Carcinoma

Germany, Switzerland
Abramson Cancer Center of the University of Pennsylvania

Completed

Topical Resiquimod for the Treatment of Early Stage Cutaneous T Cell Lymphoma (CTCL)

Cutaneous T Cell Lymphoma

United States
Graceway Pharmaceuticals, LLC

Completed

Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults

Warts
Graceway Pharmaceuticals, LLC

Completed

An up to Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects

Warts

United States
Graceway Pharmaceuticals, LLC

Completed

Four Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Pediatric Subjects

Warts

United States
Graceway Pharmaceuticals, LLC

Completed

Study With a Topical Gel to Treat Common Warts in Adults

Warts

United States
Graceway Pharmaceuticals, LLC

Completed

Twelve Week Safety and Efficacy Study With a Topical Gel to Treat Common Warts in Adults

Warts

United States
Graceway Pharmaceuticals, LLC

Completed

Study With a Topical Gel to Treat Common Warts in Adults

Warts

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Vaccine Therapy and Resiquimod in Treating Patients With Stage II, Stage III, or Stage IV Melanoma That Has Been Completely Removed by Surgery

Melanoma (Skin)

United States
University of British Columbia

Completed

Enhancing Influenza Vaccination in Seniors With TLR (Toll Like Receptor) Agonists

Influenza Vaccination in Seniors

Canada
Nina Bhardwaj
Cancer Research Institute, New York City

Completed

Randomized, Double Blind, Placebo-controlled Topical Resiquimod Adjuvant for NY-ESO-1 Protein Vaccination

Tumors

United States
M.D. Anderson Cancer Center

Completed

Tumor and Vaccine Site With a Toll Like Receptor (TLR) Agonist

Melanoma

United States
University of British Columbia

Completed

Optimizing Hepatitis B Vaccine Response Through the Use of a Topical Immune Modulator

Hepatitis B

Canada
Celldex Therapeutics

Completed

A Study of CDX-1401 in Patients With Malignancies Known to Express NY-ESO-1

Advanced Malignancies

United States
The Maas Clinic

Unknown

A Clinical Study Comparing Restylane® Silk and Belotero Balance® for the Treatment of Superficial, Vertical Perioral Lines

Perioral Rhytids

United States
National Center for Complementary and Integrative...

Completed

Pycnogenol for the Treatment of Lymphedema of the Arm in Breast Cancer Survivors

Cancer | Lymphedema | Breast

United States
Craig L Slingluff, Jr
University of Virginia

Completed

Phase I/II Trial of a Long Peptide Vaccine (LPV7) Plus TLR Agonists (MEL60)

Melanoma | Metastatic Melanoma | Mucosal Melanoma

United States
University of Sao Paulo General Hospital

Unknown

The Prevstain Trial (TPT)

Varicose Veins
Jonsson Comprehensive Cancer Center

Active, not recruiting

Dendritic Cell Vaccine for Patients With Brain Tumors

Glioma | Glioblastoma | Anaplastic Astrocytoma | Anaplastic Astro-oligodendroglioma

United States
Imperial College London

Completed

Development of Human Nasal Challenge Models With Microbial Constituents and Grass Pollen

Asthma | Latent Tuberculosis | Allergic Rhinitis

United Kingdom
Sunnybrook Health Sciences Centre

Completed

Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease

Dementia | Alzheimer's Disease

Canada
Hospices Civils de Lyon

Completed

TUMORAPA 1: Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant Recipients

Kidney Transplantation | Skin Cancer

France
Mayo Clinic
National Cancer Institute (NCI)

Completed

Vaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By Surgery

Recurrent Melanoma | Stage IV Melanoma | Stage IIIA Melanoma | Stage IIIB Melanoma | Stage IIIC Melanoma | Stage IIB Melanoma | Stage IIC Melanoma | Stage IIA Melanoma

United States

Search clinical trials for: Resiquimod

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations